FDA liver risk warning for Bristol-Myers HIV drug

February 1, 2010

(AP) -- Federal health officials say patients taking a Bristol-Myers Squibb drug for HIV have reported a rare, but potentially fatal liver disorder.

The says it received 42 reports of the disorder since Videx was approved in 1991. Four patients died from bleeding or liver failure after developing the problem, known as non-cirrhotic portal .

The problem involves dangerously slow blood flow though the liver, which can cause veins in the esophagus to swell. These veins are thin and can cause burst, causing potentially deadly bleeding.

FDA says it is keeping the drug on the market because its benefits outweigh its risks. The agency added warnings to the drug's label about the signs of the liver disorder.

Explore further: FDA OKs drug to treat bleeding disorder


Related Stories

FDA OKs drug to treat bleeding disorder

April 30, 2007

The U.S. Food and Drug Administration has approved Humate-P for the treatment of a specific bleeding disorder called von Willebrand disease.

FDA orders Trasylol temporarily withdrawn

November 5, 2007

The U.S. Food and Drug Administration has temporarily halted the use of the drug Trasylol, which is used to control bleeding during heart surgery.

FDA toughens warnings on over-the-counter painkillers

April 29, 2009

The Food and Drug Administration said Tuesday that it is asking drugmakers to more prominently display safety warnings on the labels of some of the most widely used over-the-counter pain and fever remedies.

FDA questions safety of Glaxo kidney cancer drug

October 1, 2009

(AP) -- Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.